COPENHAGEN, Feb 9 (Reuters) - Danish drugmaker Lundbeck on Monday said it would buy U.S.-based Ovation Pharmaceuticals for up to $900 million in cash to build a North American commercial platform and boost mid and long-term growth.
COPENHAGEN, Feb 9 (Reuters) - Danish drugmaker Lundbeck on Monday said it would buy U.S.-based Ovation Pharmaceuticals for up to $900 million in cash to build a North American commercial platform and boost mid and long-term growth.
